Geode Capital Management, LLC Crispr Therapeutics Ag Transaction History
Geode Capital Management, LLC
- $1.07 Trillion
- Q1 2024
A detailed history of Geode Capital Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Geode Capital Management, LLC holds 909,298 shares of CRSP stock, worth $49.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
909,298
Previous 883,729
2.89%
Holding current value
$49.6 Million
Previous $55.3 Million
12.03%
% of portfolio
0.01%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding CRSP
# of Institutions
547Shares Held
56.2MCall Options Held
2.91MPut Options Held
2.47M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.16MShares$445 Million3.97% of portfolio
-
Capital International Investors Los Angeles, CA7.84MShares$428 Million0.11% of portfolio
-
Nikko Asset Management Americas, Inc.3.27MShares$178 Million2.23% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.15MShares$172 Million0.13% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.7MShares$148 Million0.11% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.26B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....